We are live on ! Find out more
FC

Fairpointe Capital Portfolio holdings

AUM $66.3M
1-Year Est. Return 101.32%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+101.32%
3 Year Est. Return
+48.06%
5 Year Est. Return
+95.29%
10 Year Est. Return
–
AUM
$5.95B
AUM Growth
+$968M
Cap. Flow
+$572M
Cap. Flow %
9.61%
Top 10 Hldgs %
31.15%
Holding
77
New
5
Increased
36
Reduced
29
Closed
2

Top Buys

Rank Stock Value
1
XYL icon
Xylem
XYL
+$166M
2
AGCO icon
AGCO
AGCO
+$114M
3
RJF icon
Raymond James Financial
RJF
+$105M
4
CTXS
Citrix Systems Inc
CTXS
+$93.7M
5
WOLF icon
Wolfspeed
WOLF
+$49.2M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$93.9M
2
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
+$31.8M
3
LXK
Lexmark Intl Inc
LXK
+$23.1M
4
BLC
BELO CORP SER A
BLC
+$22.8M
5
CGG
CGG
CGG
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 28.24%
2 Industrials 17.22%
3 Healthcare 10.92%
4 Communication Services 10.04%
5 Financials 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSP
1
DELISTED
HOSPIRA INC
HSP
$213M 3.58%
5,427,343
-184,098
-3% -$7.34M
CVSA
2
Covista Inc
CVSA
$4.55B
$201M 3.37%
6,567,883
+457,272
+7% +$14.1M
BSX icon
3
Boston Scientific
BSX
$68.4B
$190M 3.2%
16,209,521
-8,683,284
-35% -$93.9M
NYT icon
4
New York Times
NYT
$12.6B
$189M 3.17%
15,016,672
-143,380
-0.9% -$1.7M
NUAN
5
DELISTED
Nuance Communications, Inc.
NUAN
$181M 3.04%
11,203,656
+1,887,397
+20% +$31.2M
ITRI icon
6
Itron
ITRI
$4.54B
$181M 3.04%
4,217,641
+713,945
+20% +$29.2M
JNPR
7
DELISTED
Juniper Networks
JNPR
$179M 3%
8,999,875
+904,607
+11% +$18.6M
AKAM icon
8
Akamai
AKAM
$15.6B
$177M 2.98%
3,431,657
-204,516
-6% -$9.64M
XYL icon
9
Xylem
XYL
$28.5B
$174M 2.92%
+6,216,702
New +$166M
SPLS
10
DELISTED
Staples Inc
SPLS
$169M 2.84%
11,552,291
-660,984
-5% -$10.4M
NVDA icon
11
NVIDIA
NVDA
$4.6T
$159M 2.66%
407,597,560
+14,356,240
+4% +$5.34M
JBL icon
12
Jabil
JBL
$30.1B
$157M 2.64%
7,239,720
+739,161
+11% +$16.9M
IPG
13
DELISTED
Interpublic Group of Companies
IPG
$154M 2.58%
8,937,746
-302,905
-3% -$4.88M
VAR
14
DELISTED
Varian Medical Systems, Inc.
VAR
$147M 2.46%
2,235,675
+98,330
+5% +$6.23M
MDR
15
DELISTED
McDermott International
MDR
$145M 2.44%
6,502,402
+1,426,257
+28% +$33.8M
WOLF icon
16
Wolfspeed
WOLF
$1.04B
$128M 2.15%
2,130,137
+772,771
+57% +$49.2M
FTI icon
17
TechnipFMC
FTI
$28.6B
$128M 2.14%
3,095,463
+212,360
+7% +$8.73M
WERN icon
18
Werner Enterprises
WERN
$2.2B
$126M 2.12%
5,418,058
+736,533
+16% +$17.6M
UIS icon
19
Unisys
UIS
$252M
$126M 2.11%
4,987,555
-235,754
-5% -$5.92M
TGNA
20
DELISTED
TEGNA Inc
TGNA
$123M 2.06%
8,765,946
+351,666
+4% +$4.7M
LUV icon
21
Southwest Airlines
LUV
$21.7B
$122M 2.06%
8,410,792
-678,413
-7% -$9.23M
AGCO icon
22
AGCO
AGCO
$8.41B
$122M 2.05%
+2,020,464
New +$114M
TAP icon
23
Molson Coors Class B
TAP
$8.02B
$120M 2.02%
2,394,173
+279,264
+13% +$14M
MAN icon
24
ManpowerGroup
MAN
$2.6B
$120M 2.01%
1,642,858
-146,051
-8% -$9.78M
NTRS icon
25
Northern Trust
NTRS
$21.8B
$118M 1.99%
2,176,011
+568,385
+35% +$32.6M
1
2 3

Similar funds

EFM
Ennismore Fund Management London, United Kingdom $71.7M AUM 92.16% 1-Year Est. Return
NI
Northwood Investors Denver, Colorado $73.8M AUM
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
WSC
White Square Capital London, United Kingdom $14.7M AUM 151.72% 1-Year Est. Return
AGEC
Ark Global Emerging Companies Salt Lake City, Utah $14M AUM
CIA
CSat Investment Advisory Detroit, Michigan $119M AUM 77.51% 1-Year Est. Return
FLSMF
Fundsmith Long/Short Master Fund Grand Cayman, Cayman Islands $121M AUM
OHS
Odey Holdings (Switzerland) Zurich, Switzerland, Switzerland $11.1M AUM 64.12% 1-Year Est. Return

Fairpointe Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Fairpointe Capital held 77 positions worth $5.95B, up 19% from $4.98B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Fairpointe Capital deployed $572M of net new capital in Q3 2013, opening 5 new positions and adding to 36 existing holdings. Its largest new stake was Xylem: 6,216,702 shares worth $174M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Boston Scientific, an estimated $93.9M trimmed.

  • Fairpointe Capital's largest Q3 2013 buy was Xylem: 6,216,702 shares worth $174M.
  • Fairpointe Capital added most to Wolfspeed in Q3 2013, an estimated $49.2M increase.
  • Fairpointe Capital's biggest Q3 2013 reduction was Boston Scientific, cutting an estimated $93.9M.
  • Fairpointe Capital fully exited Denbury Resources, Inc. in Q3 2013, selling an estimated $15.6M.
  • Fairpointe Capital's ten largest holdings make up 31% of its $5.95B portfolio in Q3 2013.
  • Fairpointe Capital opened 5 new positions and closed 2 in Q3 2013.
  • Fairpointe Capital's portfolio value rose 19% quarter-over-quarter to $5.95B.

Based on Fairpointe Capital's 13F filing for Q3 2013, filed 12 Nov 2013.